Oligonucleotide Synthesis Market,By Equipment and Services (Equipment/Synthesizer (Nucleic Acid Synthesizer, Peptide Synthesizer), Reagents, Services, (Oligo Synthesis, Modification, Purification)), By Technology (Column-based, Microarray-based), By Nucleic Acid (DNA, RNA), By Application (Drug Discovery, Therapeutics), By End User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical-biotechnology Companies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
Oligonucleotide therapeutics have revolutionized the pharmaceutical industry. They are a class of drugs and are composed of short strands of RNA or DNA that can be modified during synthesis in order to alter the expression of a number of disease-causing proteins.
Market players are interested in receiving approval from the regulatory authorities, and this is expected to drive the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in the year 2021, the U.S. Food and Drug Administration approved Inclisiran. Inclisiran is being developed by the Medicines Company, a subsidiary of Novartis AG, a pharmaceutical company, which licensed the rights to inclisiran from Alnylam Pharmaceuticals, an American biopharmaceutical company. Inclisiran is indicated for the treatment of cardiovascular disease and thus demonstrates the opportunity oligonucleotides present as a treatment modality for large patient populations targeting a breadth of common diseases, including cardiovascular disease, oncology, and metabolic disorders. Currently, a number of manufacturers are conducting research and development activities for the development of oligonucleotide drugs.
Market Dynamics
Market players are engaged in conducting inorganic activities such as acquisitions in order to increase their customer base. This is expected to have a positive impact on the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in January 2021, Sixfold Bioscience, a U.K.-based preclinical-stage biotechnology company, and OLIGOMED, a multidisciplinary project, announced a partnership to develop oligonucleotide therapeutics. Sixfold Bioscience also received funding from Marie Skłodowska-Curie, Innovative Training Network (ITN) to enroll PhD students in early-stage research (ESR) to improve Sixfold's in vivo oligonucleotide delivery technology.
Key features of the study:
- This report provides an in-depth analysis of the global oligonucleotide synthesis market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global oligonucleotide synthesis market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Twist Bioscience, STA Pharmaceutical Co. Ltd., KINOVATE LIFE SCIENCES, CUSABIO TECHNOLOGY LLC, Synbio Technologies, GENEWIZ, Agilent Technologies, Inc., Maravai LifeSciences Holdings, Inc., Biogen, Eurofins Scientific, Sarepta Therapeutics, Inc., LGC Limited, Kaneka Corporation, Biotage and Nitto Denko Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market
- By Equipment and Services:
- Nucleic Acid Synthesizer
- Peptide Synthesizer
- Oligo synthesis
- Modification
- Purification
- Equipment/Synthesizer
- Reagents
- Services
- By Technology:
- Column-based
- Microarray-based
- By Nucleic Acid:
- DNA
- RNA
- By Application:
- Drug Discovery
- Therapeutics
- By End User:
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-biotechnology Companies
- By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Equipment and Services
- Market Snippet, By Technology
- Market Snippet, By Nucleic Acid
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- 4. Global Oligonucleotide Synthesis Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Oligonucleotide Synthesis Market, By Equipment and Services, 2018– 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- Equipment and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- Nucleic Acid Synthesizer
- Peptide Synthesizer
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- Oligo Synthesis
- Modification
- Purification
- 6. Global Oligonucleotide Synthesis Market, By Technology, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- ColuBn-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- Microarray-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- 7. Global Oligonucleotide Synthesis Market, By Nucleic Acid, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- RNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- 8. Global Oligonucleotide Synthesis Market, By Application, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- 9. Global Oligonucleotide Synthesis Market, By End User, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- Pharmaceutical-biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Segment Trends
- 10. Global Oligonucleotide Synthesis Market, By Region, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 –2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 –2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 –2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 –2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 –2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 –2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 –2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 –2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 –2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 –2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 –2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 –2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 –2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
- 11. Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation
- 12. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 55 market data tables and 38 figures on “Global Oligonucleotide Synthesis Market” – Global forecast to 2030
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook